Population Health
Prevalence of atrial fibrillation in US adults much higher than previous estimates
Nearly one in 20 adults in the U.S. are estimated to have atrial fibrillation, many more than previous studies had indicated, according to new data out of the University of California, San Francisco.
Gout cases estimated to increase more than 70% worldwide by 2050
The total number of patients with gout across the world is estimated to increase more than 70% from 2020 to 2050, largely due to aging and population growth, according to forecasting model data published in The Lancet Rheumatology.
Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology.
Cigarette smokers more tobacco dependent vs. other tobacco product users
Tobacco dependence was greater among adults who smoked cigarettes than adults who used smokeless tobacco and multiple tobacco products, according to results published in Nicotine & Tobacco Research.
1.5 million atrial fibrillation cases may be undiagnosed in US
An analysis of five U.S. medical claims databases suggests as many as 23% of 5.6 million to 6.6 million presumptive atrial fibrillation cases are undiagnosed, with many undiagnosed patients likely eligible for oral anticoagulant treatment.
Total CVD deaths during early period of pandemic highest since 2003
Heart disease remained among the leading causes of death, even amid the COVID-19 pandemic, which may have exacerbated preexisting CVD morbidity-related racial/ethnic disparities, researchers reported.
HF prevalence may be higher than estimates in low- to middle-income countries
The age-standardized prevalence of HF in low- to middle-income countries may be much higher than modeling estimates suggest and signals the persistence of global CVD health disparities, according to researchers.
Anji, Population Health Partners enter strategic collaboration to address kidney disease
Anji Pharmaceuticals and Population Health Partners announced a strategic collaboration to accelerate the development of two clinical assets the Anji pipeline, one of which addresses kidney disease, according to the press release.
Migration associated with allergic disease among ethnic groups in the Netherlands
Intercontinental migration showed a positive association with allergies among adults from ethnic groups living in Amsterdam, the Netherlands, compared with participants of Dutch origin, according to a letter published in Allergy.
Obesity disparities greater among children attending racially segregated schools
Racial and ethnic disparities in obesity prevalence are greater among children attending more racially segregated schools compared with those attending integrated schools, according to study findings published in Obesity.